Percutaneous mitral valve repair (PMVR) with a MitraClip device has been recently introduced as a valuable therapy in high surgical risk patients with functional mitral regurgitation (FMR) who are not responding to currently available medical treatments. Our aim was to assess the clinical, functional and prognostic impact of periprocedural levosimendan administration in patients with end-stage heart failure and FMR undergoing PMVR.
|Autori:||Giannini, Cristina; Petronio, Anna; Fiorelli, Francesca; Liga, Riccardo; Spontoni, Paolo; DE CARLO, Marco; Marraccini, Emilia; Pieroni, Andrea; Guarracino, Fabio|
|Titolo:||Effects of levosimendan in patients with severe functional mitral regurgitation undergoing MitraClip implantation|
|Anno del prodotto:||2017|
|Digital Object Identifier (DOI):||10.2459/JCM.0000000000000537|
|Appare nelle tipologie:||1.1 Articolo in rivista|